ÌÇÐÄvlog´«Ã½

Transcutaneous Oximetry Systems Market Analysis

The Transcutaneous Oximetry Systems Market size is estimated at USD 137.17 million in 2024, and is expected to reach USD 186.27 million by 2029, growing at a CAGR of 6.31% during the forecast period (2024-2029).

Several factors, such as the increasing prevalence of peripheral vascular disorder and wound healing disorder, growing adoption of advanced monitoring systems for blood flow monitoring, and increasing prevalence of diabetic foot ulcers, are expected to boost market growth during the forecast period.

The rising prevalence of peripheral vascular and wound healing disorders is set to propel the growth of the transcutaneous oximetry systems market. Frequent wound-healing disorders often stem from circulatory deficiency, malnutrition, metabolic disorders, sepsis, and inflammation.

For instance, according to the Global Hunger Index, as of May 2022, about 1.5 million children under the age of five, or 45% of Somalian children, were projected to face acute malnutrition through the end of the year, including 386,400 who were expected to be severely malnourished. Thus, an increase in malnutrition leads to slow wound healing, thereby decreasing the blood oxygen level at the injury site. In such instances, transcutaneous oximetry systems are widely used for measuring oxygen levels, thereby driving the market’s growth during the forecast period.

Moreover, the rise in the utilization of transcutaneous oximetry systems in peripheral vascular disorders to detect the systems is expected to fuel market growth. For instance, an article published in November 2022 in PubMed highlighted that transcutaneous oximetry effectively detects upper limb arterial compression and related symptoms when patients with suspected thoracic outlet syndrome (TOS) perform arm abduction. These findings are expected to drive the adoption of transcutaneous oximetry systems in healthcare facilities, thereby propelling market growth.

Transcutaneous oximetry systems are increasingly utilized to assess the necessity of amputation, particularly in cases of diabetic foot ulcers, a leading cause of such procedures. For instance, an article published by the National Centre for Biotechnology Information in August 2022 highlighted that diabetic foot ulcers rank prominently among the complications faced by individuals with diabetes mellitus. These ulcers often arise from factors such as poor glycaemic control, neuropathy, peripheral vascular disease, or neglect of foot care.

In addition to the above context, approximately 60% of individuals with diabetes experience neuropathy, often resulting in foot ulcers. Globally, diabetic foot ulcers have an annual incidence ranging from 9.1 to 26.1 million cases. ÌÇÐÄvlog´«Ã½ 15% to 25% of all diabetes patients are at risk of developing these ulcers at some point in their lives.

Furthermore, as per 2022 updated data published by the International Diabetes Federation, about 643 million people are expected to suffer from diabetes in 2030 globally, and this number is projected to reach 784 million by 2045. Thus, the expected increase in the diabetic population raises its risk of developing diabetic foot ulcers, fueling the need to monitor any damage or blockage in the blood vessels. This is anticipated to propel the growth of the transcutaneous oximetry market during the forecast period.

Thus, the rise in peripheral vascular disorders, diabetic mellitus, and the increase in the adoption of transcutaneous oximetry systems for detecting oxygen levels in various diseases are expected to drive market growth. However, the high cost of transcutaneous oximetry systems is expected to restrain market growth.

Transcutaneous Oximetry Systems Market Trends

Preterm Births are Expected to Register High Growth During the Forecast Period

Transcutaneous Oximetry Systems Industry Segmentation

As per the scope of the report, transcutaneous oximetry systems are used for transcutaneous oximetry (TCPO2) tests. Transcutaneous oximetry systems are used to measure oxygen at the skin surface, which is used to know how much oxygen gets to the underlying tissue.

The transcutaneous oximetry systems market is segmented by application, end user, and geography. By application, the market is segmented into peripheral vascular disorders, diabetic foot ulcers, preterm births, and other applications. By end user, the market is bifurcated into hospitals, clinics, and other end users. By geography, the market is divided into North America, Europe, Asia-Pacific, Middle East and Africa, and South America. The report offers the value (USD) for the above segments.